OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
Timothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 2, pp. 2101724-2101724
Open Access | Times Cited: 45
Timothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 2, pp. 2101724-2101724
Open Access | Times Cited: 45
Showing 26-50 of 45 citing articles:
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, et al.
ERJ Open Research (2022) Vol. 8, Iss. 1, pp. 00610-2021
Open Access | Times Cited: 6
Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, et al.
ERJ Open Research (2022) Vol. 8, Iss. 1, pp. 00610-2021
Open Access | Times Cited: 6
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics
Denise Battaglini, Fernanda F. Cruz, Chiara Robba, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 995-1015
Closed Access | Times Cited: 6
Denise Battaglini, Fernanda F. Cruz, Chiara Robba, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 995-1015
Closed Access | Times Cited: 6
Exploring the relationship between anellovirus load and clinical variables in hospitalized COVID-19 patients: Implications for immune activation and inflammation
Marijn Thijssen, Timothy Devos, Geert Meyfroidt, et al.
IJID Regions (2023) Vol. 9, pp. 49-54
Open Access | Times Cited: 3
Marijn Thijssen, Timothy Devos, Geert Meyfroidt, et al.
IJID Regions (2023) Vol. 9, pp. 49-54
Open Access | Times Cited: 3
COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
Cindy Ke Zhou, Monica Bennett, Carlos H. Villa, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273223-e0273223
Open Access | Times Cited: 5
Cindy Ke Zhou, Monica Bennett, Carlos H. Villa, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273223-e0273223
Open Access | Times Cited: 5
Efficacy and Safety of COVID-19 Treatment Using Convalescent Plasma Transfusion: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hyun‐Jun Lee, Junhyeong Lee, Yejin Cho, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10622-10622
Open Access | Times Cited: 4
Hyun‐Jun Lee, Junhyeong Lee, Yejin Cho, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10622-10622
Open Access | Times Cited: 4
TheEuropean Respiratory Journal: the ERS flagship heads for the next frontier
James D. Chalmers, Don D. Sin
European Respiratory Journal (2023) Vol. 61, Iss. 1, pp. 2202475-2202475
Closed Access | Times Cited: 2
James D. Chalmers, Don D. Sin
European Respiratory Journal (2023) Vol. 61, Iss. 1, pp. 2202475-2202475
Closed Access | Times Cited: 2
Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?
Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 5
Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 5
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Sixten Körper, Eva Schrezenmeier, Héctor Rincón-Arévalo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Sixten Körper, Eva Schrezenmeier, Héctor Rincón-Arévalo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients
Carlo J. Iasella, S. Hannan, Emily Lyons, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309449-e0309449
Open Access
Carlo J. Iasella, S. Hannan, Emily Lyons, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309449-e0309449
Open Access
Convalescent plasma for SARS-CoV-2 infection: win or learn
Enric Contreras-Barbeta, Anna Millán, Jordi Rello
European Respiratory Journal (2021) Vol. 59, Iss. 2, pp. 2102076-2102076
Open Access | Times Cited: 3
Enric Contreras-Barbeta, Anna Millán, Jordi Rello
European Respiratory Journal (2021) Vol. 59, Iss. 2, pp. 2102076-2102076
Open Access | Times Cited: 3
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza
Catherine Kimber, Abigail Lamikanra, Louise Geneen, et al.
Transfusion Medicine (2022) Vol. 33, Iss. 1, pp. 26-38
Open Access | Times Cited: 2
Catherine Kimber, Abigail Lamikanra, Louise Geneen, et al.
Transfusion Medicine (2022) Vol. 33, Iss. 1, pp. 26-38
Open Access | Times Cited: 2
Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better
Maya Hites, Jean‐Louis Vincent
Viruses (2022) Vol. 14, Iss. 7, pp. 1427-1427
Open Access | Times Cited: 1
Maya Hites, Jean‐Louis Vincent
Viruses (2022) Vol. 14, Iss. 7, pp. 1427-1427
Open Access | Times Cited: 1
Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary
Noémi Kiss-Dala, Bálint Gergely Szabó, Botond Lakatos, et al.
GeroScience (2022) Vol. 44, Iss. 5, pp. 2427-2445
Open Access | Times Cited: 1
Noémi Kiss-Dala, Bálint Gergely Szabó, Botond Lakatos, et al.
GeroScience (2022) Vol. 44, Iss. 5, pp. 2427-2445
Open Access | Times Cited: 1
Effectiveness of convalescent plasma therapy for COVID-19 patients infected with variants of concerns
Eighty Mardiyan Kurniawati, Innas Safira Putri, Deandra Maharani Widiatmaja, et al.
Anaesthesia Pain & Intensive Care (2022) Vol. 26, Iss. 4, pp. 535-545
Open Access | Times Cited: 1
Eighty Mardiyan Kurniawati, Innas Safira Putri, Deandra Maharani Widiatmaja, et al.
Anaesthesia Pain & Intensive Care (2022) Vol. 26, Iss. 4, pp. 535-545
Open Access | Times Cited: 1
COVID-19 convalescent plasma: current status, lessons from the past and future perspectives
Tor Hervig, Øystein Flesland, Lise Sofie Haug Nissen‐Meyer
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 4, pp. 103487-103487
Open Access
Tor Hervig, Øystein Flesland, Lise Sofie Haug Nissen‐Meyer
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 4, pp. 103487-103487
Open Access
Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent Plasma
Fabrice Cognasse, Hind Hamzeh‐Cognasse, Mickaël Rosa, et al.
SSRN Electronic Journal (2022)
Closed Access
Fabrice Cognasse, Hind Hamzeh‐Cognasse, Mickaël Rosa, et al.
SSRN Electronic Journal (2022)
Closed Access
Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature
Sonia Whang, Vivek Shah, Lu Pu, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 958-958
Open Access
Sonia Whang, Vivek Shah, Lu Pu, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 958-958
Open Access
Randomisierte Studien zum Einsatz von Rekonvaleszentenplasma bei COVID-19: eine Standortbestimmung
Sixten Körper, Thomas Appl, Bernd Jahrsdörfer, et al.
Transfusionsmedizin (2021) Vol. 11, Iss. 04, pp. 223-240
Closed Access
Sixten Körper, Thomas Appl, Bernd Jahrsdörfer, et al.
Transfusionsmedizin (2021) Vol. 11, Iss. 04, pp. 223-240
Closed Access
